Buy Tesamorelin Ipamorelin Blend in Australia
Buy Tesamorelin Ipamorelin in Australia from Macropus Peptides as one research vial holding 13mg of Tesamorelin and 3mg of Ipamorelin, freeze-dried together. Tesamorelin is a full-length growth hormone releasing hormone analogue acting on the GHRH receptor, and Ipamorelin is a selective agonist of the ghrelin receptor, so the pair lets a laboratory study both pituitary inputs from one preparation. The vial is priced and in stock, and it costs the same as a single 10mg Tesamorelin vial while holding more Tesamorelin plus the Ipamorelin, which makes it the cheaper route when both compounds are needed at this ratio. Each vial is sealed and labelled with both compounds, the amount of each, lot number and storage temperature, and the lot's certificate of analysis is available on request. The two single peptides are also stocked for control arms. Add bacteriostatic water and the order ships from local Australian stock to any Australian address, for in-vitro research by adults 18 and over only, never for human or veterinary use.
| Compound | Tesamorelin + Ipamorelin |
|---|---|
| Amount | 13 + 3 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Tesamorelin + Ipamorelin 13 + 3mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy Tesamorelin Ipamorelin Blend Australia: 13mg + 3mg in One Vial
Macropus Peptides supplies this two-peptide research vial at a set price: 13 milligrams of Tesamorelin and 3 milligrams of Ipamorelin in a single freeze-dried cake, 16 milligrams in all. It exists for laboratories that study the two pituitary receptors for growth hormone release together and want one lot number, one reconstitution and one ratio that never drifts between preparations.
What is the Tesamorelin Ipamorelin blend
The vial pairs two peptides from opposite sides of growth hormone control. Tesamorelin is all 44 amino acids of human growth hormone releasing hormone with a hexenoyl cap that protects it from DPP-4, the enzyme that inactivates the natural hormone. Ipamorelin is a five amino acid agonist of the ghrelin receptor, first described as the earliest selective growth hormone secretagogue. Neither peptide is changed by being combined; they are simply dried together at a mass ratio of 13 to 3, and that split is printed on the label.
Why Tesamorelin and Ipamorelin are combined
Growth hormone cells in the pituitary answer to two separate receptors. The GHRH receptor works through cyclic AMP; the ghrelin receptor works through calcium. Stimulating both at once produces a bigger growth hormone response than either can manage alone, an effect studied in pituitary research for decades. Choosing this particular pair also has a logic: Tesamorelin is the GHRH analogue with the largest clinical record, and Ipamorelin is the ghrelin-side peptide with the narrowest effect on cortisol and prolactin, so the combined signal stays focused on growth hormone.
How the Tesamorelin Ipamorelin blend works in research
In a model system, the Tesamorelin half raises cyclic AMP in somatotrophs and primes growth hormone synthesis, while the Ipamorelin half triggers the calcium signal that releases stored hormone. Researchers use the blend to measure how the two signals add together, how quickly the response returns to baseline, and how downstream IGF-1 output follows. The heavier Tesamorelin share reflects its larger molecular size: at 44 amino acids each molecule weighs about seven times as much as the pentapeptide.
Tesamorelin and Ipamorelin research: what the studies show
Each component has its own published record. The ghrelin-side peptide was characterised in 1998 (European Journal of Endocrinology) as a secretagogue that released growth hormone without raising ACTH or cortisol in animal models. On the GHRH side, Tesamorelin trials (New England Journal of Medicine, 2007; JAMA, 2014) measured visceral fat and liver fat in adults with HIV. Published work on the two in one preparation is limited, which is why combination research remains largely preclinical. Our Tesamorelin and Ipamorelin research studies library lists the papers behind each component.
Tesamorelin Ipamorelin vial specifications
| Specification | Detail |
|---|---|
| Compound | Tesamorelin + Ipamorelin |
| Amount | 13 + 3 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
The two peptides share one lyophilised cake in a stoppered, crimped glass vial. Its label lists both compound names with their individual masses, 13mg and 3mg, plus the lot number and storage temperature. Its matching analysis certificate reports both components; quote the lot number and we send it. Freezer storage at -20 °C, in the carton, protects the unopened blend.
Tesamorelin Ipamorelin price in Australia
| Strength | Price | Price per mg |
|---|---|---|
| Tesamorelin + Ipamorelin 13 + 3mg | $159.99 | $10.00 per mg |
The blend sells for the same checkout price as one 10mg Tesamorelin vial, yet holds 13mg of Tesamorelin plus 3mg of Ipamorelin. Measured per milligram of Tesamorelin alone, that is already cheaper than the single vial, and the Ipamorelin comes on top.
Tesamorelin Ipamorelin 13 + 3mg: where to buy in Australia
This is the only size of the blend, and it is ready to order. A single vial covers a set of paired experiments on one lot, with both compounds released from the same cake whenever it is reconstituted.
Tesamorelin Ipamorelin blend or the two single vials: which to buy
Buying Tesamorelin and Ipamorelin separately costs noticeably more for a two-compound study and adds weighing and mixing steps where error can creep in. The singles still earn their place: a control arm that needs one peptide alone, or a study where the ratio itself is the variable, needs them. For a GHRH partner with a shorter backbone, the CJC-1295 and Ipamorelin blend swaps Tesamorelin for CJC-1295 no DAC.
Best place to buy Tesamorelin Ipamorelin in Australia
- 13mg and 3mg co-lyophilised at a ratio that is identical in every vial
- A checkout price that undercuts buying the components separately
- Both masses on the label and on the lot certificate
- Single-peptide vials available for controls
- Shipped from Australian stock with no import step
How to order the Tesamorelin Ipamorelin blend online
- Add the 13mg plus 3mg vial to your cart
- Add the single peptides if a control arm needs them
- Put bacteriostatic water in the order for reconstitution
- Tick the over-18 and bench-use boxes while paying
- File the lot number that arrives on the label
Tesamorelin Ipamorelin calculator: bac water for the 16mg vial
Because the vial holds two compounds, work out each one. With 2 mL of bacteriostatic water, every millilitre carries 6.5mg of Tesamorelin and 1.5mg of Ipamorelin (8 mg per mL combined). With 4 mL, each millilitre carries 3.25mg and 0.75mg (4 mg per mL combined). The ratio stays at 13 to 3 whatever volume you choose. Order bacteriostatic water with the blend so both arrive together.
Is Tesamorelin Ipamorelin available in Australia
Here the combination trades purely as research material. Neither peptide appears on the ARTG, and the blend is not an approved product anywhere, so no sale for people or animals is allowed. Both releasing factors and secretagogues for growth hormone fall under TGA scheduling, and the latest Poisons Standard text governs what your organisation may hold.
Tesamorelin and Ipamorelin for sale Australia wide
Blend parcels are boxed at our Australian base for laboratories across the mainland and Tasmania. Further combinations and singles sit within the growth hormone research range, including CJC-1295 with DAC and Sermorelin.
References
- Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998.
- Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine. 2007.
- Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014.
- A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.